Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

290 ta ish

Ish: Peptide drugs for obesity and type 2 diabetes mellitus: an overview of clinical trials

  1. Therapeutic peptides: current applications and future directions

    Lei Wang, Nanxi Wang, Wenping Zhang +6

    Sharh maqola20225 iqtibos
    ABI

  2. Nanoparticles as Drug Delivery Systems: A Review of the Implication of Nanoparticles’ Physicochemical Properties on Responses in Biological Systems

    Azeez Yusuf, Awatif Rashed Z. Almotairy, Hanan A. Henidi +2

    Sharh maqola20234 iqtibos
    ABI

  3. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

    Steven P. Marso, Stephen C. Bain, Agostino Consoli +12

    Boshqa20163 iqtibos
    ABI

  4. Polymer-Based Hydrogels Applied in Drug Delivery: An Overview

    Hoc Thang Nguyen, Truong Bach Chien, Đặng Xuân Cường

    Sharh maqola20233 iqtibos
    ABI

  5. Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines

    Wen‐Jing Xiao, Wenjie Jiang, Zheng Chen +5

    Sharh maqola20253 iqtibos
    ABI

  6. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

    Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen +12

    Maqola20162 iqtibos
    ABI

  7. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

    Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais +97

    Maqola20192 iqtibos
    ABI

  8. Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial

    Ania M. Jastreboff, Lee M. Kaplan, Juan P. Frías +7

    Maqola20232 iqtibos
    ABI

  9. The Cardiovascular Effect of Tirzepatide: A Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide Dual Agonist

    Yun Kyung Cho, Yoo La Lee, Chang Hee Jung

    Sharh maqola20232 iqtibos
    ABI

  10. Designing hydrogels for controlled drug delivery

    Jianyu Li, David Mooney

    Sharh maqola20162 iqtibos
    ABI

  11. Tirzepatide Once Weekly for the Treatment of Obesity

    Ania M. Jastreboff, Louis J. Aronne, Nadia N. Ahmad +8

    Maqola20222 iqtibos
    ABI

  12. Alopecia and Semaglutide: Connecting the Dots for Patient Safety

    Diala Haykal

    Boshqa20252 iqtibos
    ABI

  13. Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis

    Ali Aminian, Abbas Al‐Kurd, Rickesha Wilson +13

    Maqola20212 iqtibos
    ABI

  14. Backbone N-methylation of peptides: Advances in synthesis and applications in pharmaceutical drug development

    Xuefei Li, Ningchao Wang, Yuhang Liu +4

    Sharh maqola20232 iqtibos
    ABI

  15. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021

    Masayuki Teramoto, Emmanuela Gakidou, Justin Lo +97

    Maqola20252 iqtibos
    ABI

  16. PEG shedding-rate-dependent blood clearance of PEGylated lipid nanoparticles in mice: Faster PEG shedding attenuates anti-PEG IgM production

    Takuya Suzuki, Yuta Suzuki, Taro Hihara +6

    Maqola20202 iqtibos
    ABI

  17. Incretin hormones: Their role in health and disease

    Michael A. Nauck, Juris J. Meier

    Sharh maqola20182 iqtibos
    ABI

  18. Translational Applications of Hydrogels

    Santiago Correa, Abigail K. Grosskopf, Hector Lopez Hernandez +4

    Sharh maqola20212 iqtibos
    ABI

  19. Hydrophilic Gels for Biological Use

    O. Wichterle, D. Lím

    Maqola19602 iqtibos
    ABI

  20. Complement activation-related pseudoallergy: A stress reaction in blood triggered by nanomedicines and biologicals

    János Szebeni

    Sharh maqola20142 iqtibos
    ABI

  21. Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial

    Christopher Sorli, Shin‐ichi Harashima, George Tsoukas +4

    Maqola20172 iqtibos
    ABI

  22. Regulation and function of the mammalian tricarboxylic acid cycle

    Paige K. Arnold, Lydia W.S. Finley

    Sharh maqola20222 iqtibos
    ABI

  23. Alveolarides: Antifungal Peptides from <i>Microascus alveolaris</i> Active against Phytopathogenic Fungi

    Serge Fotso, Paul R. Graupner, Quanbo Xiong +5

    Maqola20172 iqtibos
    ABI

  24. Trends in peptide drug discovery

    Markus Muttenthaler, Glenn F. King, David J. Adams +1

    Sharh maqola20212 iqtibos
    ABI

  25. Advances in Hydrogel-Based Drug Delivery Systems

    Boya Liu, Kuo Chen

    Maqola20242 iqtibos
    ABI